Biotech · Private company
Hutchison Medipharma Limited
Track this companyFree. Adds Hutchison Medipharma Limited to your Dealase workspace and tells you when its record changes.
Clinical trials132 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- FruquintinibPhase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- HMPL-004Phase 3 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- HMPL-004 1800 mg/dayPhase 3 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- HMPL-004 2400 mg/dayPhase 3 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- FruquintinibPhase 1 · Drug Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- Fruquintinib (HMPL-013)Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- fruquintinib with food/fruquintinib without food/fruquintinib with rabeprazolePhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- fruquintinib without food/fruquintinib with food/fruquintinib with rabeprazolePhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · Drug Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- Part APhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Part BPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- RifampinPhase 1 · Drug Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- surufatinibPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- SurufatinibPhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- SurufatinibPhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- Surufatinib Renal Impairment StudyPHASE1 · COMPLETED · started Feb 12, 2021ClinicalTrials.gov NCT04755088 · fetched Nov 12, 2026
- Surufatinib Hepatic Impairment StudyPHASE1 · COMPLETED · started Feb 12, 2021ClinicalTrials.gov NCT04755075 · fetched Nov 12, 2026
- Fruquintinib Food Effect and Proton Pump Inhibitor StudyPHASE1 · COMPLETED · started Sep 24, 2020ClinicalTrials.gov NCT04645940 · fetched Nov 12, 2026
- Fruquintinib CYP3A Inhibitor and Inducer StudyPHASE1 · COMPLETED · started Sep 2, 2020ClinicalTrials.gov NCT04557397 · fetched Nov 12, 2026
- A Study to Assess the Effect of a High Fat Meal on Surufatinib in Healthy SubjectsPHASE1 · COMPLETED · started Aug 14, 2020ClinicalTrials.gov NCT04372394 · fetched Nov 12, 2026
- A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal CancerPHASE3 · COMPLETED · started Aug 12, 2020ClinicalTrials.gov NCT04322539 · fetched Nov 12, 2026
- A Study to Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy SubjectsPHASE1 · COMPLETED · started Jul 9, 2020ClinicalTrials.gov NCT04372407 · fetched Nov 12, 2026
- Surufatinib DDI With a PPI and a CYP3A InducerPHASE1 · COMPLETED · started Jul 9, 2020ClinicalTrials.gov NCT04510649 · fetched Nov 12, 2026
- Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior OsimertinibPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 9, 2019ClinicalTrials.gov NCT03778229 · fetched Nov 12, 2026
- A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersPHASE1 · COMPLETED · started Dec 11, 2017ClinicalTrials.gov NCT03251378 · fetched Nov 12, 2026
- Savolitinib vs. Sunitinib in MET-driven PRCC.PHASE3 · ACTIVE_NOT_RECRUITING · started Jul 25, 2017ClinicalTrials.gov NCT03091192 · fetched Nov 12, 2026
- HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative ColitisPHASE3 · TERMINATED · started Jun 1, 2013ClinicalTrials.gov NCT01882764 · fetched Nov 12, 2026
- A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative ColitisPHASE3 · TERMINATED · started Mar 1, 2013ClinicalTrials.gov NCT01805791 · fetched Nov 12, 2026